AT Bancorp’s GSK GSK Stock Holding History

AT Bancorp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$264K	Buy	5,062 +827	+20%	+$41.3K	0.03%	210
2018 Q4	$202K	Hold	4,235	–	–	0.03%	217
2018 Q3	$213K	Hold	4,235	–	–	0.02%	214
2018 Q2	$213K	Hold	4,235	–	–	0.02%	219
2018 Q1	$207K	Buy	+4,235	New	+$197K	0.02%	221
2017 Q4	–	Sell	-4,555	Closed	-$231K	–	233
2017 Q3	$231K	Sell	4,555 -828	-15%	-$42K	0.03%	214
2017 Q2	$290K	Hold	5,383	–	–	0.03%	211
2017 Q1	$284K	Sell	5,383 -1,239	-19%	-$62.9K	0.04%	235
2016 Q4	$320K	Buy	6,622 +76	+1%	+$3.75K	0.04%	233
2016 Q3	$353K	Hold	6,546	–	–	0.05%	217
2016 Q2	$354K	Hold	6,546	–	–	0.05%	194
2016 Q1	$332K	Buy	6,546 +356	+6%	+$17.7K	0.05%	191
2015 Q4	$313K	Sell	6,190 -34	-0.5%	-$1.73K	0.09%	159
2015 Q3	$299K	Buy	6,224 +1,312	+27%	+$68.3K	0.09%	159
2015 Q2	$256K	Buy	4,912 +456	+10%	+$25.7K	0.07%	183
2015 Q1	$257K	Hold	4,456	–	–	0.07%	179
2014 Q4	$238K	Hold	4,456	–	–	0.07%	179
2014 Q3	$255K	Buy	4,456 +215	+5%	+$13.2K	0.07%	175
2014 Q2	$284K	Buy	4,241 +80	+2%	+$5.42K	0.09%	164
2014 Q1	$278K	Buy	4,161 +54	+1%	+$3.65K	0.09%	155
2013 Q4	$274K	Buy	4,107 +587	+17%	+$38.1K	0.08%	147
2013 Q3	$221K	Hold	3,520	–	–	0.08%	155
2013 Q2	$220K	Buy	+3,520	New	+$223K	0.08%	161

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

AT Bancorp's GSK Position: Q1 2019 in Review

AT Bancorp increased its GSK (GSK) stake by 20% in Q1 2019, buying an estimated $41.3K and bringing the position to 5,062 shares worth $264K. The position accounts for 0.03% of the portfolio, ranked #210.

AT Bancorp first reported a position in GSK in Q2 2013 and has held it in 23 quarters since. The position peaked at $354K in Q2 2016. 847 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

AT Bancorp held 5,062 shares of GSK worth $264K as of Q1 2019.
AT Bancorp bought 827 GSK shares in Q1 2019, an estimated $41.3K.
GSK made up 0.03% of AT Bancorp's portfolio in Q1 2019, its #210 holding.
AT Bancorp first reported a position in GSK in Q2 2013 and has held it in 23 quarters since.
AT Bancorp's GSK position peaked at $354K in Q2 2016.
847 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.